HK/China Healthcare Analyst (ex-Fosun Pharma)

Xinyao (Criss) Wang

Over 15 years' experience in both finance and healthcare, covering clinic operations, investment and equity research in both China and overseas.

Industry Report - Insights on China IVD Industry

Industry Report - Insights on China Vaccine Industry

Pre-IPO Raily Aesthetic Medicine (2135.HK) - Here Are the Concerns

Pre-IPO MicroPort CardioFlow - A Better Candidate of the TAVR Market in China?

Pre-IPO Basecare Medical - Here Are the the Strengths and Concerns

Battle Lines Drawn As BABA Builds Out First/Last-Mile Capacity; But Who Will Fund 75+ Bn CNY CapEx?

Thematic (Sector/Industry)

Hong kong Healthcare equipment and services / Thematic (Sector/Industry)

<p>With the development of the times, people have a higher standard for their own image. More and more young people seek to improve their appearance, so as to gain certain advantages in social contact, life, job hunting and work. Such trend is stimulating consumer demand for beauty. Under this background, it directly promotes the rapid growth of the medical beauty industry in China.</p>

With the development of the times, people have a higher standard for their own image. More and more young people seek to improve their appearance, so as to gain certain advantages in social contact, life, job hunting and work. Such trend is stimulating consumer demand for beauty. Under this background, it directly promotes the rapid growth of the medical beauty industry in China.

Raily Aesthetic Medicine International Holdings Limited (2135 HK)

Raily Aesthetic Medicine International Holdings Limited

Industry Report - Insights on China Medical Beauty Industry